Journal of Medicinal Chemistry
Brief Article
(
14) Liu, G.; Oettel, K.; Bailey, H.; Ummersen, L. V.; Tutsch, K.;
(33) Zhang, J.; Ponomareva, L. V.; Marchillo, K.; Zhou, M.; Andes,
D. R.; Thorson, J. S. Synthesis and antibacterial activity of doxycycline
neoglycosides. J. Nat. Prod. 2013, 76, 1627−1636.
(34) Griffith, B. R.; Krepel, C.; Fu, X.; Blanchard, S.; Ahmed, A.;
Edmiston, C. E.; Thorson, J. S. A model for antibiotic optimization via
neoglycosylation: synthesis of liponeoglycopeptides active against
VRE. J. Am. Chem. Soc. 2007, 129, 8150−8155.
Staab, M. J.; Horvath, D.; Alberti, D.; Arzoomanian, R.; Rezazadeh, H.;
McGovern, J.; Robinson, E.; DeMets, D.; Wilding, G. Phase II trial of
perillyl alcohol (NSC 641066) administered daily in patients with
metastatic androgen independent prostate cancer. Invest. New Drug
2
(
003, 21, 367−372.
15) Meadows, S. M.; Mulkerin, D.; Berlin, J.; Bailey, H.; Kolesar, J.;
Warren, D.; Thomas, J. P. Phase II trial of perillyl alcohol in patients
with metastatic colorectal cancer. Int. J. Gastrointest. Cancer 2002, 32,
(35) Kushwaha, D.; Dwivedi, P.; Kuanar, S. K.; Tiwari, V. K. Click
reaction in carbohydrate chemistry: recent developments and future
perspective. Curr. Org. Synth. 2013, 10, 90−135.
1
(
25−128.
(36) Fu, X.; Albermann, C.; Jiang, J. Q.; Liao, J. C.; Zhang, C. S.;
16) Ripple, G. H.; Gould, M. N.; Stewart, J. A.; Tutsch, K. D.;
Thorson, J. S. Antibiotic optimization via in vitro glycorandomization.
Arzoomanian, R. Z.; Alberti, D.; Feierabend, C.; Pomplun, M.;
Wilding, G.; Bailey, H. H. Phase I clinical trial of perillyl alcohol
administered daily. Clin. Cancer. Res. 1998, 4, 1159−1164.
Nature Biotechnol. 2003, 21, 1467−1469.
(37) Carrasco, M. R.; Brown, R. T.; Serafimova, I. M.; Silva, O.
Synthesis of N-Fmoc-O-(N′-Boc-N′-methyl)-aminohomoserine, an
amino acid for the facile preparation of neoglycopeptides. J. Org.
Chem. 2003, 68, 195−197.
(
̃
17) da Fonseca, C. O.; Simao, M.; Lins, I. R.; Caetano, R. O.;
Futuro, D.; Quirico-Santos, T. Efficacy of monoterpene perillyl alcohol
upon survival rate of patients with recurrent glioblastoma. J. Cancer
Res. Clin. Oncol. 2011, 137, 287−293.
(38) Carrasco, M. R.; Brown, R. T. A versatile set of aminooxy amino
acids for the synthesis of neoglycopeptides. J. Org. Chem. 2003, 68,
853−8858.
39) Goff, R. D.; Thorson, J. S. Assessment of chemoselective
(
18) da Fonseca, C. O.; Schwartsmann, G.; Fischer, J.; Nagel, J.;
8
(
Futuro, D.; Quirico-Santos, T.; Gattass, C. R. Preliminary results from
a phase I/II study of perillyl alcohol intranasal administration in adults
with recurrent malignant gliomas. Surg. Neurol. 2008, 70, 259−266.
neoglycosylation methods using chlorambucil as a model. J. Med.
Chem. 2010, 53, 8129−8139.
(
19) Cho, H. Y.; Wang, W.; Jhaveri, N.; Torres, S.; Tseng, J.; Leong,
M. N.; Lee, D. J.; Goldkorn, A.; Xu, T.; Petasis, N. A.; Louie, S. G.;
Schonthal, A. H.; Hofman, F. M.; Chen, T. C. Perillyl alcohol for the
treatment of Temozolomide-resistant gliomas. Mol. Cancer Ther. 2012,
1, 2462−2472.
20) Gantt, R. W.; Peltier-Pain, P.; Thorson, J. S. Enzymatic methods
(40) Ahmed, A.; Peters, N. R.; Fitzgerald, M. K.; Watson, J. A., Jr.;
Hoffmann, F. M.; Thorson, J. S. Colchicine glycorandomization
influences cytotoxicity and mechanism of action. J. Am. Chem. Soc.
̈
2
(
006, 128, 14224−14225.
41) Goff, R. D.; Singh, S.; Thorson, J. S. Glycosyloxyamine
neoglycosylation: a model study using calicheamicin. ChemMedChem
011, 6, 774−776.
42) Peltier-Pain, P.; Marchillo, K.; Zhou, M. Q.; Andes, D. R.;
1
(
for glyco(diversification/randomization) of drugs and small molecules.
2
(
Nat. Prod. Rep. 2011, 28, 1811−1853.
(
21) Fujita, T.; Ohira, K.; Miyatake, K.; Nakano, Y.; Nakayama, M.
Thorson, J. S. Natural product disaccharide engineering through
tandem glycosyltransferase catalysis reversibility and neoglycosylation.
Org. Lett. 2012, 14, 5086−5089.
Inhibitory effect of perilloside A and C, and related monoterpene
mlucosides on aldose reductase and their structure−activity relation-
ships. Chem. Pharm. Bull. 1995, 43, 920−926.
(43) Cipolla, L.; Peri, F. Carbohydrate-based bioactive compounds
(
22) Fujita, T.; Funayoshi, A.; Nakayama, M. A phenylpropanoid
for medicinal chemistry applications. Mini-Rev. Med. Chem. 2011, 11,
9−54.
44) Langenhan, J. M.; Endo, M. M.; Engle, J. M.; Fukumoto, L. L.;
glucoside from Perilla frutescens. Phytochemistry 1994, 37, 543−546.
23) Fujita, T.; Nakayama, M. Monoterpene glucosides and other
constituents from Perilla frutescens. Phytochemistry 1993, 34, 1545−
548.
24) Fujita, T.; Nakayama, M.; Perilloside, A. A monoterpene
glucoside from Perilla frutescens. Phytochemistry 1992, 31, 3265−3267.
25) Xanthakis, E.; Magkouta, S.; Loutrari, H.; Stamatis, H.; Roussos,
3
(
(
Rogalsky, D. R.; Slevin, L. K.; Fay, L. R.; Lucker, R. W.; Rohlfing, J. R.;
Smith, K. R.; Tjaden, A. E.; Werner, H. M. Synthesis and biological
evaluation of RON-neoglycosides as tumor cytotoxins. Carbohydr. Res.
1
(
2
(
011, 346, 2663−2676.
(
45) Langenhan, J. M.; Mullarky, E.; Rogalsky, D. K.; Rohlfing, J. R.;
C.; Kolisis, F. N. Enzymatic synthesis of perillyl alcohol derivatives and
investigation of their antiproliferative activity. Biocatal. Biotransform.
Tjaden, A. E.; Werner, H. M.; Rozal, L. M.; Loskot, S. A.
Amphimedosides A−C: synthesis, chemoselective glycosylation, and
biological evaluation. J. Org. Chem. 2013, 78, 1670−1676.
2
(
009, 27, 1−9.
26) Shimoda, K.; Sakamoto, S.; Nakajima, N.; Hamada, H.; Hamada,
(46) Langenhan, J. M.; Griffith, B. R.; Thorson, J. S. Neo-
H. Synthesis of unnatural mono- and oligosaccharides of farnesol,
geraniol, and (S)-perillyl alcohol by biocatalytic glycosylations. Chem.
Lett. 2008, 37, 556−557.
glycorandomization and chemoenzymatic glycorandomization: two
complementary tools for natural product diversification. J. Nat. Prod.
2
(
005, 68, 1696−1711.
(
27) Arafa, H. M. M. Possible contribution of beta-glycosidases and
47) Langenhan, J. M.; Engle, J. M.; Slevin, L. K.; Fay, L. R.; Lucker,
caspases in the cytotoxicity of novel glycoconjugates in colon cancer
R. W.; Smith, K. R.; Endo, M. M. Modifying the glycosidic linkage in
digitoxin analogs provides selective cytotoxins. Bioorg. Med. Chem. Lett.
cells. Invest. New Drug 2010, 28, 306−317.
(
28) Goff, R. D.; Thorson, J. S. Neoglycosylation and neo-
2
(
008, 18, 670−673.
glycorandomization: enabling tools for the discovery of novel
glycosylated bioactive probes and early stage leads. MedChemComm
48) Carrasco, M. R.; Alvarado, C. I.; Dashner, S. T.; Wong, A. J.;
Wong, M. A. Synthesis of aminooxy and N-alkylaminooxy amines for
use in bioconjugation. J. Org. Chem. 2010, 75, 5757−5759.
2
(
014, 5, 1036−1047, DOI: 10.1039/C4MD00117F.
29) Lin, C.-K.; Lu, T.-J. A simple method for the oxidation of
(49) Filira, F.; Biondi, B.; Biondi, L.; Giannini, E.; Gobbo, M.; Negri,
primary alcohols with o-iodoxybenzoic acid (IBX) in the presence of
acetic acid. Tetrahedron 2010, 66, 9688−9693.
L.; Rocchi, R. Opioid peptides: synthesis and biological properties of
γ
γ
4
[(N -glucosyl,N -methoxy)-α,γ-diamino-(S)-butanoyl] -deltorphin-1-
neoglycopeptide and related analogues. Org. Biomol. Chem. 2003, 1,
3059−3063.
(
30) Goff, R. D.; Thorson, J. S. Enhancement of cyclopamine via
conjugation with nonmetabolic sugars. Org. Lett. 2012, 14, 2454−
457.
31) Peltier-Pain, P.; Timmons, S. C.; Grandemange, A.; Benoit, E.;
2
(
(50) Ruvinsky, I.; Meyuhas, O. Ribosomal protein S6 phosphor-
ylation: from protein synthesis to cell size. Trends Biochem. Sci. 2006,
31, 342−348.
(51) Eummer, J. T.; Gibbs, B. S.; Zahn, T. J.; Sebolt-Leopold, J. S.;
Gibbs, R. A. Novel limonene phosphonate and farnesyl diphosphate
analogues: design, synthesis, and evaluation as potential protein-
farnesyl transferase inhibitors. Bioorg. Med. Chem. 1999, 7, 241−250.
Thorson, J. S. Warfarin glycosylation invokes a switch from
anticoagulant to anticancer activity. ChemMedChem 2011, 6, 1347−
1350.
(
32) Goff, R. D.; Thorson, J. S. Enhancing the divergent activities of
betulinic acid via neoglycosylation. Org. Lett. 2009, 11, 461−464.
7
483
dx.doi.org/10.1021/jm500870u | J. Med. Chem. 2014, 57, 7478−7484